Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.43 |
| ▸ | MMP3 | P08254 | 1/20 | 0.43 |
| ▸ | REN | P00797 | 1/20 | 0.41 |
| ▸ | TLR2 | O60603 | 1/20 | 0.41 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.41 |
| ▸ | FAP | Q12884 | 1/20 | 0.40 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.39 |
| ▸ | APLNR | P35414 | 1/20 | 0.38 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.38 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.38 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.38 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.38 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.38 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.38 |
| ▸ | CMA1 | P23946 | 1/20 | 0.38 |
| ▸ | RAMP3 | O60896 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30313548 | 0.97 | MMP1 (0.42) | MMP1MMP3RENTLR2TLR1 | |
| SCHEMBL30313483 | 0.95 | MMP1 (0.44) | MMP1MMP3RENTLR2TLR1 | |
| SCHEMBL30313493 | 0.93 | REN (0.40) | MMP1MMP3RENAPLNRNMUR2 | |
| SCHEMBL30313541 | 0.92 | MDM2 (0.44) | TLR2TLR1MDM2ITGB3ITGA2B | |
| SCHEMBL31297108 | 0.91 | REN (0.46) | RENFAPAPLNROPRM1OPRK1 | |
| SCHEMBL30313501 | 0.91 | REN (0.40) | MMP1MMP3RENAPLNRNMUR2 | |
| SCHEMBL30313466 | 0.90 | TLR2 (0.48) | TLR2TLR1FAPMDM2ITGB3 | |
| SCHEMBL31297104 | 0.88 | REN (0.46) | RENTLR2FAPAPLNROPRM1 | |
| SCHEMBL31297115 | 0.86 | APLNR (0.45) | MMP1MMP3RENTLR2APLNR | |
| SCHEMBL30313512 | 0.85 | RAMP3 (0.38) | MMP1MMP3RENAPLNRNMUR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230312648-A1 | PEPTIDES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE DISEASES | YUYU PHARMA, INC. (KR) | 2023-10-05 | — | — | US | disclosed |
| US-11613558-B2 | Peptides and pharmaceutical compositions for treating eye diseases | YUYU PHARMA, INC. (KR) | 2023-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312648-A1 | PEPTIDES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE DISEASES | VIP, IAPP, SCTR | MMP1 728/4885MMP3 480/4885REN 907/4885 |
| US-11613558-B2 | Peptides and pharmaceutical compositions for treating eye diseases | VIP, IAPP, SCTR | MMP1 728/4885MMP3 480/4885REN 907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.